Expand IINN Menu
IINN MENU

IINN Latest Press Releases

-- February 18, 2026 --

Inspira Expands U.S. Commercial Footprint: Deploys ART100 at a New Premier New York Academic Medical Center, Ranked Top 10 in New York State Globe Newswire 8:32 AM

-- February 17, 2026 --

Inspira Accelerates U.S. Commercial Strategy: FDA-Cleared ART100 Targets Market Adoption at AmSECT 2026 via Glo-Med Networks Globe Newswire 8:00 AM

-- February 12, 2026 --

Inspira Technologies Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Requirement Globe Newswire 4:01 PM

-- February 9, 2026 --

Inspira Secures Vendor Approval from $12 Billion Revenue HMO (World's 2nd Largest), Enabling Immediate ART100 Deployment Globe Newswire 7:00 AM

-- February 5, 2026 --

Inspira Announces Pricing of $4.75 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market under Nasdaq Rules Globe Newswire 8:00 AM

-- February 3, 2026 --

Inspira Technologies Validates Next-Gen Standalone HYLA Blood Sensor with Clinical-Grade Accuracy, Targeting $48 Billion Heart-Lung Surgery Market Globe Newswire 9:22 AM

-- January 29, 2026 --

ART100 Becomes Inspira's First System to Complete Clinical Evaluation and Enters Budgeted Procurement at Top U.S. Medical Center Globe Newswire 8:30 AM

-- January 21, 2026 --

Inspira Advances to Final Governmental Budgetary Validation Procedures for Previously Announced Binding Purchase Orders Globe Newswire 8:50 AM

-- January 8, 2026 --

Inspira Outlines Strategic Vision and Transaction Framework for Breast Cancer Liquid Biopsy Expansion Globe Newswire 8:50 AM

-- January 5, 2026 --

CORRECTION - Inspira Signs Term Sheet for Acquisition of Advanced Liquid Biopsy Cancer Diagnostics Technology and Investment of $15 Million into Inspira at $180 Million Valuation Globe Newswire 10:46 AM
Inspira Signs Term Sheet for Acquisition of Advanced Liquid Biopsy Cancer Diagnostics Technology and Concurrent $15 Million Investment at $180 Million Valuation Globe Newswire 9:30 AM

-- December 23, 2025 --

Inspira Technologies Reaffirms $49.5 Million in Binding Purchase Orders and Aligns Execution with 2026 Regulatory and Deployment Milestones Globe Newswire 8:30 AM

-- December 15, 2025 --

Inspira Announces $1.8 Million Registered Direct Offering Priced At-The-Market and Additional Equity Financing Agreement to Support Ongoing Commercial Execution Globe Newswire 8:30 AM

-- December 9, 2025 --

Inspira Technologies Granted Patent in Japan for the INSPIRA ART System's Convertible Dual Lumen Cannula Device and Method of Use Globe Newswire 8:05 AM

-- December 3, 2025 --

Inspira Technologies Announces Strategic Leap in Lab Capabilities - Accelerating Next-Generation Diagnostics and Blood Technology Globe Newswire 8:43 AM

-- November 13, 2025 --

Inspira Completes Clinical Study for HYLA Blood Sensor - Ahead of Regulatory Submission Globe Newswire 9:00 AM

-- November 6, 2025 --

Inspira Technologies Nears Final Regulatory Clearance for the ART100 in the UAE, Accelerating Gulf Region Expansion Globe Newswire 9:10 AM

-- October 22, 2025 --

Inspira and Bites Form Strategic Alliance to Embed AI as a Core Standard Across Inspira's Global Ecosystem Globe Newswire 8:30 AM

-- October 21, 2025 --

Inspira Appoints Former Johnson & Johnson Senior Business Manager as VP of Global Sales and New Board Member from a Leading International Investment Firm Globe Newswire 3:40 PM
Inspira Appoints Former Johnson & Johnson Executive as VP of Global Sales and New Board Member from a Leading International Investment Firm Globe Newswire 9:05 AM

-- October 1, 2025 --

Inspira Technologies Reports First Half 2025 Financial Results and Issues Business Update Globe Newswire 8:00 AM
Market Data Delayed 15 Minutes